Cough Assist Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Choice of Delivery, By End User, By Region & Competition, 2021-2031F

The Global market for cough assist devices is anticipated to expand from USD 3.11 billion in 2025 to USD 4.87 billion by 2031, representing a compound annual growth rate of 7.76%. Also referred to as mechanical insufflation-exsufflation devices, these specialized respiratory tools help clear airway secretions for individuals with compromised natural coughing abilities. They function by delivering positive pressure to inflate the lungs before rapidly switching to negative pressure, which mimics a forceful exhalation to successfully loosen and extract mucus. Market growth is primarily driven by the escalating prevalence of chronic respiratory conditions like Chronic Obstructive Pulmonary Disease and cystic fibrosis, alongside a growing incidence of neuromuscular disorders such as muscular dystrophy and spinal cord injuries that weaken breathing muscles. Additionally, the increasing global elderly population, which is highly vulnerable to respiratory illnesses, and the ongoing transition toward home-based healthcare are significantly boosting the demand for these non-invasive airway clearance options.

A major hurdle hindering the expansion of this market is the high initial cost required to acquire these advanced devices, creating a substantial obstacle for numerous healthcare facilities and individual patients. Furthermore, inadequate or fluctuating reimbursement frameworks across different regions add to the financial strain on both patients and institutions, which could limit widespread acceptance. Highlighting the scale of the broader industry context, MedTech Europe estimated the European medical technology market-which includes a wide array of medical devices-to be worth roughly €170 billion in 2024.

Market Driver

A key factor propelling the global cough assist devices market is the rising frequency of chronic respiratory and neuromuscular conditions. Ailments like cystic fibrosis, Chronic Obstructive Pulmonary Disease, spinal cord injuries, and muscular dystrophy compromise the body's natural coughing mechanism, making external airway clearance essential. By delivering critical mechanical insufflation-exsufflation, cough assist devices help dislodge and clear secretions, thereby avoiding further health complications and enhancing the patient's overall quality of life. Emphasizing the scale of this issue, a Global Burden of Disease study published in Nature Medicine in January 2026 indicated that almost 570 million individuals globally were affected by chronic respiratory diseases in 2023, forming a massive patient demographic that continuously drives the need for reliable airway clearance therapies.

In addition, shifting global demographics toward an aging population significantly impact the expansion of this market. Seniors are naturally more vulnerable to respiratory illnesses and face a greater risk of developing long-term conditions that weaken their ability to cough effectively. As the global percentage of older adults grows, the number of individuals vulnerable to compromised airway clearance simultaneously rises. Underscoring this trend toward an older society, United Nations projections revealed that individuals aged 65 and older accounted for 10.3 percent of the global population in 2024. This enduring requirement for respiratory assistance among the elderly heavily promotes the utilization of cough assist devices, a demand reflected by Fisher & Paykel Healthcare Corporation Limited's report of $2.02 billion in total operating revenue for the fiscal year ending March 31, 2025, highlighting strong outcomes within its respiratory care divisions.

Market Challenge

The steep purchasing price of cough assist devices poses a significant barrier to the growth of the market. Although these specialized respiratory instruments are vital for individuals lacking a natural cough reflex, they require a heavy financial outlay from both individual patients and healthcare providers. Such expensive initial investments can severely restrict purchasing capabilities, especially within healthcare networks facing tight budgetary limits or in geographical areas characterized by reduced per-capita medical expenditures.

This economic strain has a direct consequence on the availability and widespread integration of such advanced respiratory technologies. Highlighting the impact of rising expenses, AdvaMed's Q4 2025 Report released in January 2026 noted that more than 360 public comments backed their warning that tariff-driven price hikes on medical technologies would severely hinder patient access and disrupt the supply chain. This reflects a unified industry perspective that rising costs create immediate obstacles for patients in need of essential medical tools, consequently stifling the extensive distribution and commercial growth of sophisticated equipment like cough assist devices. Ultimately, the requirement for heavy capital investment restricts numerous medical centers from purchasing and incorporating these essential devices into their routine patient care procedures.

Market Trends

A major trend transforming the global market for cough assist devices is the continual innovation toward miniaturization and the creation of highly intuitive user interfaces. This movement is fueled by a wider industry initiative to design medical equipment that is highly portable, less obtrusive, and much easier for caregivers and patients to manage, particularly outside of traditional clinical environments. These improvements boost treatment compliance and elevate the overall quality of life by allowing the equipment to seamlessly blend into daily schedules. Prioritizing usability and sophisticated design also stimulates extensive research and development investments across the medical technology field; as noted by Medical Product Outsourcing in January 2026, IDA Ireland clients committed a record-breaking €2.5 billion toward future research, development, and innovation in 2025, illustrating a strong dedication to advancing new technologies and product designs.

Another pivotal trend significantly impacting the cough assist devices sector is the incorporation of remote monitoring and telehealth functionalities. This transition empowers medical professionals to observe patient compliance, track device operation, and assess vital physiological metrics from afar, enabling prompt medical interventions and customized therapy modifications while minimizing the necessity of frequent physical appointments. Remote supervision provides continuous care and exceptional convenience for individuals battling chronic respiratory illnesses, ultimately fostering better long-term health results and lowering hospital admission rates. This highly connected strategy broadens the scope of specialized respiratory therapies far beyond conventional medical facilities, a phenomenon demonstrated by ResMed Inc.'s January 2026 report for Q2 FY26, which revealed that their AirView platform actively manages upward of 35 million patients, highlighting the massive integration and effectiveness of digital health solutions in respiratory medicine.

Key Market Players

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• Hayek Medical
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

Report Scope

In this report, the Global Cough Assist Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cough Assist Devices Market, By Type

• Automatic
• Manual

Cough Assist Devices Market, By Choice of Delivery

• Face Mask
• Mouthpiece
• Adapter

Cough Assist Devices Market, By End User

• Hospitals & Clinics
• Ambulatory Care Settings
• Homecare
• Others

Cough Assist Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cough Assist Devices Market.

Available Customizations:

Global Cough Assist Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).